Professor Dickon Hayne

Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone +61 8 94312004

Map

Selected grants

2019

  • BCG+MM Trial: Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, non´┐Żmuscle-invasive bladder cancer: a 2-stage, randomised phase 3 trial.; Hayne D, Stockler M, Frydenberg M, Martin A, Sengupta S, Patel M, Grummet J, Krieger L, McCombie S; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • Adding mitomycin C to intravesical BCG for high-risk, non-muscle-invasive bladder cancer: a randomised phase 3 trial; Hayne D, Patel M, Stockler M, Sengupta S, Frydenberg M, Chalasani V, Gebski V, Davis I; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

To update your profile click here. For support on your academic profile contact .